Diclofenac mediated derangement of neuroblastoma cell lipidomic profiles is accompanied by increased phosphatidylcholine biosynthesis

Adv Enzyme Regul. 2008:48:74-87. doi: 10.1016/j.advenzreg.2007.11.005. Epub 2007 Nov 19.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diclofenac / pharmacology*
  • Diglycerides / metabolism
  • Humans
  • Lipid Metabolism / drug effects*
  • Neuroblastoma / metabolism*
  • Phosphatidylcholines / biosynthesis*
  • Phosphatidylinositols / metabolism
  • Phosphatidylserines / metabolism
  • Phospholipase A2 Inhibitors
  • Phospholipases A2 / metabolism*
  • Tumor Cells, Cultured

Substances

  • Diglycerides
  • Phosphatidylcholines
  • Phosphatidylinositols
  • Phosphatidylserines
  • Phospholipase A2 Inhibitors
  • Diclofenac
  • Phospholipases A2